Zentalis Pharmaceuticals Inc (ZNTL)
11.27
-0.01
(-0.09%)
USD |
NASDAQ |
May 24, 16:00
11.28
+0.01
(+0.09%)
After-Hours: 20:00
Zentalis Pharmaceuticals 1 Year Total Returns (Daily): -57.63% for May 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 24, 2024 | -57.63% |
May 23, 2024 | -57.82% |
May 22, 2024 | -56.12% |
May 21, 2024 | -56.05% |
May 20, 2024 | -55.26% |
May 17, 2024 | -54.64% |
May 16, 2024 | -56.76% |
May 15, 2024 | -57.26% |
May 14, 2024 | -56.60% |
May 13, 2024 | -56.30% |
May 10, 2024 | -48.59% |
May 09, 2024 | -45.11% |
May 08, 2024 | -43.14% |
May 07, 2024 | -44.77% |
May 06, 2024 | -47.42% |
May 03, 2024 | -45.10% |
May 02, 2024 | -47.59% |
May 01, 2024 | -48.38% |
April 30, 2024 | -49.80% |
April 29, 2024 | -48.16% |
April 26, 2024 | -48.39% |
April 25, 2024 | -49.59% |
April 24, 2024 | -45.26% |
April 23, 2024 | -40.14% |
April 22, 2024 | -38.10% |
Date | Value |
---|---|
April 19, 2024 | -35.65% |
April 18, 2024 | -37.98% |
April 17, 2024 | -35.19% |
April 16, 2024 | -29.39% |
April 15, 2024 | -27.25% |
April 12, 2024 | -23.37% |
April 11, 2024 | -23.76% |
April 10, 2024 | -15.39% |
April 09, 2024 | -12.41% |
April 08, 2024 | -18.64% |
April 05, 2024 | -14.17% |
April 04, 2024 | -12.41% |
April 03, 2024 | -12.79% |
April 02, 2024 | -16.10% |
April 01, 2024 | -6.22% |
March 28, 2024 | -6.86% |
March 27, 2024 | -13.99% |
March 26, 2024 | -17.84% |
March 25, 2024 | -20.82% |
March 22, 2024 | -24.21% |
March 21, 2024 | -25.37% |
March 20, 2024 | -25.75% |
March 19, 2024 | -26.08% |
March 18, 2024 | -26.39% |
March 15, 2024 | -21.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-78.35%
Minimum
Dec 28 2022
156.2%
Maximum
Sep 08 2021
-8.51%
Average
-18.02%
Median
1 Year Total Returns (Daily) Benchmarks
Revolution Medicines Inc | 44.35% |
Day One Biopharmaceuticals Inc | 11.14% |
Perspective Therapeutics Inc | 197.9% |
Electromed Inc | 34.82% |
Xtant Medical Holdings Inc | 12.10% |